Zura Bio Ltd

Insider momentum at Zura Bio shows executives buying options at $6.43, signaling confidence amid a 28 % price surge and potential upside if the pipeline advances.

CEO Sandeep Kulkarni’s recent share‑option exercise shows strong confidence in Zura Bio’s clinical pipeline and long‑term growth, signaling management alignment and potential upside for investors.